DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2022

	September 30, 2022
Common shares issuable upon exercise of employee and non-employee stock options		2,775,998
Common shares issuable upon settlement of deferred stock units		134,402
Common shares issuable upon exercise of common share purchase warrants		265,000
Shares available for grant under the 2019 Omnibus Incentive Plan		2,014,010
Shares available for grant under the 2021 Employment Inducement Incentive Plan		535,000
Total		5,724,410